Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / / Edited by Veysel Kayser
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Titolo: |
Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / / Edited by Veysel Kayser
|
| Pubblicazione: | Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2022 |
| ©2022 | |
| Descrizione fisica: | 1 online resource (298 pages) |
| Disciplina: | 338.476151 |
| Soggetto topico: | Pharmaceutical industry |
| Persona (resp. second.): | KayserVeysel |
| Nota di bibliografia: | Includes bibliographical references and index. |
| Sommario/riassunto: | The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment. |
| Titolo autorizzato: | Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910674028403321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |